期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

X射线诱导肝癌多药耐药细胞模型生物学特性的实验研究

A study of biological characteristics of hepatoma cells with multidrug resistance induced by X-ray
原文传递
导出
摘要 目前，药物介入性治疗是肝癌的重要临床处理手段，但肿瘤细胞多药耐药（MDR）严重限制了疗效。因此研究肝癌MDR细胞生物学特性，能够为肿瘤MDR逆转方法的探讨提供理论依据，对于改善肝癌的治疗有着积极意义。本实验采用X射线诱导建立人肝癌HepG2耐药细胞模型并对其生物学特性进行研究。
作者 蒋明东 彭志平 李少林 尹小玲
机构地区 重庆市第九人民医院肿瘤科 重庆医科大学核医学教研室
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2007年第9期701-702,共2页 Chinese Journal of Hepatology
关键词 X线 癌 肝细胞 多药耐药 X-rays Carcinoma, hepatoceUular Muhidrug resistance
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献5

  • 1Zerbini A. PiIli M, Ferrari C. et al. Is there a role for immunotherapy in hepatocellular carcinoma? Dig Liver Dis. 2006. 38:221-225.
  • 2Hill BT. Whelan RD, Hurst HC, et al. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X- irradiation. Cancer, 1994, 73: 2990-2999.
  • 3Gebel TW, Leister M. Schumann W, et al. Low-level self-tolerance to arsenite in human HepG2 cells is associated with a depressed induction of micronuclei. Murat Res. 2002, 514: 245-255.
  • 4蒋明东,彭志平,李少林,王志刚,冉海涛,霍塞虎,尹小玲.反义寡核苷酸并超声微泡造影剂转染联合超声照射逆转肝癌多药耐药[J].中华肝脏病杂志,2006,14(5):341-345. 被引量：6
  • 5Bodo A, Bakos E. Szeri F, et al. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol Lett, 2003, 140-141: 133-143.

二级参考文献12

  • 1Zaffaroni N,Lualdi S,Villa R,et al.Inhibition of telomerase activity by a distamycin derivative:effects on cell proliferation and induction of apoptosis in human cancer cells.Eur J Cancer,2002,38:1792-1801.
  • 2He L,Liu GQ.Interaction of multidrug resistance reversal agents with Pglycoprotein ATPase activity on blood-brain barrier.Acta Pharmacol Sin,2002,23:423-429.
  • 3Fojo T,Bates S.Strategies for reversing drug resistance.Oncogene,2003,22:7512-7523.
  • 4Bodo A,Bakos E,Szeri F,et al.The role of multidrug transporters in drug availability,metabolism and toxicity.Toxicol Lett,2003,140-141:133-143.
  • 5Pan L,Tong Y,Jin Y,et al.Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdrl in vitro by antisense oligodeoxynucleotides.Chin Med J (Engl),2001,114:929-932.
  • 6Itoh M,Noutomi T,Chiba H,et al.BcI-xL antisense treatment sensitizes Bcl-xL-overexpressing squamous cell carcinoma cells to carboplatin.Oral Oncol,2002,38:752-756.
  • 7Masanek U,Stammler G,Volm M.Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170and PKC isoenzymes with antisense oligonucleotides.J Exp Ther Oncol,2002,2:37-41.
  • 8Tsang WP,Chau SP,Fung KP,et al.Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells.Cancer Chemother Pharmacol,2003,51:161-166.
  • 9van de Donk NW,Kamphuis MM,van Dijk M,et al.Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.Leukemia,2003,17:211-219.
  • 10Stuart DD,Kao GY,Allen TM.A novel,long-circulating,and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.Cancer Gene Ther,2000,7:466-475.

共引文献5

中华肝脏病杂志
2007年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部